2. Cauley JA. Osteoporosis: fracture epidemiology update 2016. Curr Opin Rheumatol 2017;29:150-156.
4. Riggs BL, Melton LJ 3rd. The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone 1995;17:505s-511s.
6. Kim J, Lee E, Kim S, et al. Economic burden of osteoporotic fracture of the elderly in South Korea: A national survey. Value Health Reg Issues 2016;9:36-41.
10. Mitchell P, Akesson K, Chandran M, et al. Implementation of models of care for secondary osteoporotic fracture prevention and orthogeriatric models of care for osteoporotic hip fracture. Best Pract Res Clin Rheumatol 2016;30:536-558.
14. McCloskey EV, Harvey NC, Johansson H, et al. FRAX updates 2016. Curr Opin Rheumatol 2016;28:433-441.
15. Kanis JA, Harvey NC, Johansson H, et al. FRAX update. J Clin Densitom 2017;20:360-367.
16. McCloskey E, Johansson H, Oden A, et al. Fracture risk assessment. Clin Biochem 2012;45:887-893.
20. Gregg EW, Cauley JA, Seeley DG, et al. Physical activity and osteoporotic fracture risk in older women. Study of Osteoporotic Fractures Research Group. Ann Intern Med 1998;129:81-88.
21. Schousboe JT, Fink HA, Lui LY, et al. Association between prior non-spine non-hip fractures or prevalent radiographic vertebral deformities known to be at least 10 years old and incident hip fracture. J Bone Miner Res 2006;21:1557-1564.
24. Kang BJ, Lee YK, Lee KW, et al. Mortality after hip fractures in nonagenarians. J Bone Metab 2012;19:83-86.
25. Paksima N, Koval KJ, Aharanoff G, et al. Predictors of mortality after hip fracture: a 10-year prospective study. Bull NYU Hosp Jt Dis 2008;66:111-117.
26. Villareal DT, Fontana L, Weiss EP, et al. Bone mineral density response to caloric restriction-induced weight loss or exercise-induced weight loss: a randomized controlled trial. Arch Intern Med 2006;166:2502-2510.
28. Langlois JA, Visser M, Davidovic LS, et al. Hip fracture risk in older white men is associated with change in body weight from age 50 years to old age. Arch Intern Med 1998;158:990-996.
30. Bohlken J, Jacob L, Schaum P, et al. Hip fracture risk in patients with dementia in German primary care practices. Dementia (London) 2017;16:853-864.
33. Miller PD, Barlas S, Brenneman SK, et al. An approach to identifying osteopenic women at increased short-term risk of fracture. Arch Intern Med 2004;164:1113-1120.
34. Wainwright SA, Marshall LM, Ensrud KE, et al. Hip fracture in women without osteoporosis. J Clin Endocrinol Metab 2005;90:2787-2793.
35. Giangregorio LM, Leslie WD, Lix LM, et al. FRAX underestimates fracture risk in patients with diabetes. J Bone Miner Res 2012;27:301-308.
36. Leib ES, Saag KG, Adachi JD, et al. Official positions for FRAX(®) clinical regarding glucocorticoids: the impact of the use of glucocorticoids on the estimate by FRAX(®) of the 10 year risk of fracture from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(®). J Clin Densitom 2011;14:212-219.